These results are in line with previous evidence that ZEB1 directly binds to the EPCAM promoter, leading to a ZEB1-dependent repression of EPCAM expression in human pancreatic and breast cancer cell lines [93]. This evidence concerns the gene ZEB1 and breast cancer.